Volume 179, Issue 2 (February 2022)
EDITOR'S NOTE
1. Spanning Treatment Modalities: Psychotherapy, Psychopharmacology, and Neuromodulation
- Ned H. Kalin, M.D.
- Pages:75–78
- PDF
EDITORIALS
2. Making Therapy Widely Available: Clinical Research Triumph or Existential Catastrophe?
- A. John Rush, M.D.
- Pages:79–82
- PDF
3. Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression
- Charles B. Nemeroff, M.D., Ph.D.
- Pages:83–84
- PDF
4. Accelerated Intermittent Theta Burst Stimulation: Expediting and Enhancing Treatment Outcomes in Treatment-Resistant Depression
- Cory R. Weissman, M.D., Zafiris J. Daskalakis, M.D., Ph.D.
- Pages:85–87
- PDF
5. Growing Up With ADHD Symptoms: Smooth Transitions or a Bumpy Course?
- Philip Shaw, B.M., B.Ch., Ph.D.
- Pages:88–89
- PDF
COMMENTARY
6. The Neglected Role of Psychotherapy for Treatment-Resistant Depression
- John C. Markowitz, M.D., Jesse H. Wright, M.D., Ph.D., Frenk Peeters, M.D., Ph.D., Michael E. Thase, M.D., James H. Kocsis, M.D., Donna M. Sudak, M.D.
- Pages:90–93
- PDF
CLINICAL CASE CONFERENCE
7. Using Principles of Trauma-Informed Care to Address Structural Racism in Psychiatric Care
- Lila Flavin, M.D., Mira Hammoud-Milad, M.D., Kira Labinger, B.A., Nicole Wimberger, M.D., Caitlin Stork, M.D., Helena Hansen, M.D., Ph.D.
- Pages:94–97
- PDF
REVIEWS AND OVERVIEWS
8. Risks and Benefits of Cannabis and Cannabinoids in Psychiatry
- Kevin P. Hill, M.D., M.H.S., Mark S. Gold, M.D., Charles B. Nemeroff, M.D., Ph.D., William McDonald, M.D., Adrienne Grzenda, M.D., Ph.D., Alik S. Widge, M.D., Ph.D., Carolyn Rodriguez, M.D., Ph.D., Nina V. Kraguljac, M.D., John H. Krystal, M.D., Linda L. Carpenter, M.D.
- Pages:98–109
- PDF
ARTICLES
9. Trends in Outpatient Psychotherapy Provision by U.S. Psychiatrists: 1996–2016
- Daniel Tadmon, M.Phil., Mark Olfson, M.D., M.P.H.
- Pages:110–121
- PDF
10. REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial
- Maurizio Fava, M.D., Stephen Stahl, M.D., Luca Pani, M.D., Sara De Martin, Pharm.D., Marco Pappagallo, M.D., Clotilde Guidetti, M.D., Andrea Alimonti, M.D., Ezio Bettini, Ph.D., Richard M. Mangano, Ph.D., … See all authors
- Pages:122–131
- PDF
11. Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
- Eleanor J. Cole, Ph.D., Angela L. Phillips, Ph.D., Brandon S. Bentzley, M.D., Ph.D., Katy H. Stimpson, B.S., Romina Nejad, M.S., Fahim Barmak, M.D., Clive Veerapal, B.S., Naushaba Khan, B.S., … See all authors
- Pages:132–141
- PDF
12. Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD
- Margaret H. Sibley, Ph.D., L. Eugene Arnold, M.D., James M. Swanson, Ph.D., Lily T. Hechtman, M.D., Traci M. Kennedy, Ph.D., Elizabeth Owens, Ph.D., Brooke S.G. Molina, Ph.D., Peter S. Jensen, M.D., … See all authors
- Pages:142–151
- PDF
13. Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
- Meryem Grabski, Ph.D., Amy McAndrew, Ph.D., Will Lawn, Ph.D., Beth Marsh, B.Sc., Laura Raymen, M.Sc., Tobias Stevens, Ph.D., Lorna Hardy, Ph.D., Fiona Warren, Ph.D., Michael Bloomfield, Ph.D., … See all authors
- Pages:152–162
- PDF
LETTERS TO THE EDITOR
14. Intentional Drug Overdose Deaths in the United States
- Beth Han, M.D., Ph.D., M.P.H., Wilson M. Compton, M.D., M.P.E., Emily B. Einstein, Ph.D., Jessica Cotto, M.P.H., Jennifer A. Hobin, Ph.D., Jack B. Stein, M.S.W., Ph.D., Nora D. Volkow, M.D.
- Pages:163–165
- PDF
15. Surging Racial Disparities in the U.S. Overdose Crisis
- Joseph Friedman, M.P.H., Leo Beletsky, J.D., M.P.H., Ayana Jordan, M.D., Ph.D.
- Pages:166–169
- PDF